Sulfated cholecystokinin octapeptide (CCK-8) was administered either i
ntraperitoneally or into the cerebral ventricle of fully conscious mic
e, and locomotor activity was quantified. CCK-8 administered by either
route suppressed locomotor activity. Subcutaneously administered sele
ctive CCK-A receptor antagonist, L-364.718 (1 mg/kg), reversed the inh
ibitory effect of centrally as well as peripherally administered CCK-8
, but the selective CCK-B receptor antagonist, L-365,260 (1 mg/kg), di
d not. These results demonstrate that centrally as well as peripherall
y administered CCK-8 suppresses locomotor activity in mice through an
interaction with CCK-A, but not CCK-B, receptors.